Showing 25791 - 25800 of 27784 for "Pharmaceuticals and life sciences" with applied filters
21 January 2016 by Alexander Vogel, Wolfgang Muller and Debora Durrer-Kern
Alexander Vogel, Wolfgang Muller and Debora Durrer-Kern of Meyerlustenberger Lachenal explore the restructuring options available to Swiss companies in times of difficulty
08 January 2016 by Kochański Zięba & Partners
PRESS RELEASE, Warsaw, 8 January, 2016
08 January 2016 by Avellum Partners
PRESS RELEASE, Kiev, 31 December, 2015
06 January 2016 by Igor Svechkar and Anastasia Usova
Igor Svechkar and Anastasia Usova of Asters review the merger control regime in Ukraine
06 January 2016 by Gönenç Gürkaynak and Zeynep Ortaç
Gönenç Gürkaynak and Zeynep Ortaç of ELIG Attorneys-at-Law review the merger control regime in Turkey
06 January 2016 by Margaret Huang and Victor Chang
Margaret Huang and Victor Chang of LCS & Partners review the merger control regime in Taiwan
06 January 2016 by Tatsuo Yamashima and Saori Hanada
Tatsuo Yamashima and Saori Hanada of Atsumi & Sakai review the merger control regime in Japan
06 January 2016 by Abir Roy and Geetanjali Sharma
Abir Roy and Geetanjali Sharma of Lakshmikumaran & Sridharan review the merger control regime in India
06 January 2016 by Jet Deng and Ken Dai
Jet Deng and Ken Dai of Dacheng Law Offices review the merger control regime in China
06 January 2016 by Luky I Walalangi and Miriam Andreta
Luky I Walalangi and Miriam Andreta of Ali Budiardjo Nugroho Reksodiputro review the merger control regime in Indonesia
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com